Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (141-150 of 587) with videos related to

Pageof 59
Sort By:
Metabolic Syndrome and Related Disorders|May 29, 2020
The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese PopulationXiuying Zhang, Xianghai Zhou, Xueyao Han, et al.
Journal of Proteome Research|August 25, 2009
Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statusesXiuying Zhang, Yulan Wang, Fuhua Hao, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 21, 2018
Correction to: Insulin Injection Technique in China Compared with the Rest of the WorldZhenqiang Song, Xiaohui Guo, Linong Ji, et al.
Inflammopharmacology|March 19, 2025
The association between anti-inflammatory therapies and renal outcomes in patients with established cardiovascular disease or high cardiovascular risks: a meta-analysis of randomised controlled trialsWenfeng Yang, Zonglin Li, Chu Lin, et al.
Thyroid : Official Journal of the American Thyroid Association|March 12, 2026
<i>Letter:</i> Temporal Glycemic Patterns During IGF-1R Inhibitor Therapy for Thyroid Eye Disease: A Pooled Analysis of Two Clinical TrialsWei Zhao, Tianyuan Li, Junjie Deng, et al.
Frontiers in Pharmacology|December 9, 2022
Disparities in efficacy and safety of sodium-glucose cotransporter 2 inhibitor among patients with different extents of renal dysfunction: A systematic review and meta-analysis of randomized controlled trialsSuiyuan Hu, Chu Lin, Xiaoling Cai, et al.
Diabetes & Vascular Disease Research|May 29, 2013
Individualized glycaemic targets and pharmacotherapy in type 2 diabetesClifford J Bailey, Pablo Aschner, Stefano Del Prato, et al.
Neuro Endocrinology Letters|March 6, 2018
A pituitary abscess with one year follow-up after conservative treatment: A case reportNing Yuan, Sanbao Chai, Jianbin Sun, et al.
Medicine|September 20, 2022
Reduction of C-reactive protein, low-density lipoprotein cholesterol, and its relationship with cardiovascular events of different lipid-lowering therapies: A systematic review and meta-analysis of randomized controlled trialsWenjia Yang, Xiaoling Cai, Chu Lin, et al.
Journal of Diabetes|July 10, 2023
Sensitivity to thyroid hormone and risk of components of metabolic syndrome in a Chinese euthyroid populationFang Lv, Xiaoling Cai, Yufeng Li, et al.
Pageof 59

Showing results (141-150 of 587) with videos related to

Sort By:
Pageof 59
Metabolic Syndrome and Related Disorders|May 29, 2020
The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese PopulationXiuying Zhang, Xianghai Zhou, Xueyao Han, et al.
Journal of Proteome Research|August 25, 2009
Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statusesXiuying Zhang, Yulan Wang, Fuhua Hao, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 21, 2018
Correction to: Insulin Injection Technique in China Compared with the Rest of the WorldZhenqiang Song, Xiaohui Guo, Linong Ji, et al.
Inflammopharmacology|March 19, 2025
The association between anti-inflammatory therapies and renal outcomes in patients with established cardiovascular disease or high cardiovascular risks: a meta-analysis of randomised controlled trialsWenfeng Yang, Zonglin Li, Chu Lin, et al.
Thyroid : Official Journal of the American Thyroid Association|March 12, 2026
<i>Letter:</i> Temporal Glycemic Patterns During IGF-1R Inhibitor Therapy for Thyroid Eye Disease: A Pooled Analysis of Two Clinical TrialsWei Zhao, Tianyuan Li, Junjie Deng, et al.
Frontiers in Pharmacology|December 9, 2022
Disparities in efficacy and safety of sodium-glucose cotransporter 2 inhibitor among patients with different extents of renal dysfunction: A systematic review and meta-analysis of randomized controlled trialsSuiyuan Hu, Chu Lin, Xiaoling Cai, et al.
Diabetes & Vascular Disease Research|May 29, 2013
Individualized glycaemic targets and pharmacotherapy in type 2 diabetesClifford J Bailey, Pablo Aschner, Stefano Del Prato, et al.
Neuro Endocrinology Letters|March 6, 2018
A pituitary abscess with one year follow-up after conservative treatment: A case reportNing Yuan, Sanbao Chai, Jianbin Sun, et al.
Medicine|September 20, 2022
Reduction of C-reactive protein, low-density lipoprotein cholesterol, and its relationship with cardiovascular events of different lipid-lowering therapies: A systematic review and meta-analysis of randomized controlled trialsWenjia Yang, Xiaoling Cai, Chu Lin, et al.
Journal of Diabetes|July 10, 2023
Sensitivity to thyroid hormone and risk of components of metabolic syndrome in a Chinese euthyroid populationFang Lv, Xiaoling Cai, Yufeng Li, et al.
Pageof 59